Canopy Growth Corporation (CGC) concluded trading on Wednesday at a closing price of $1.05, with 4.51 million shares of worth about $4.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -77.02% during that period and on March 26, 2025 the price saw a loss of about -4.55%. Currently the company’s common shares owned by public are about 154.83M shares, out of which, 154.03M shares are available for trading.
Stock saw a price change of -7.89% in past 5 days and over the past one month there was a price change of -30.00%. Year-to-date (YTD), CGC shares are showing a performance of -61.68% which decreased to -86.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.05 but also hit the highest price of $14.92 during that period. The average intraday trading volume for Canopy Growth Corporation shares is 7.84 million. The stock is currently trading -10.24% below its 20-day simple moving average (SMA20), while that difference is down -37.06% for SMA50 and it goes to -75.28% lower than SMA200.
Canopy Growth Corporation (NASDAQ: CGC) currently have 154.83M outstanding shares and institutions hold larger chunk of about 6.33% of that.
The stock has a current market capitalization of $162.57M and its 3Y-monthly beta is at 0.84. It has posted earnings per share of -$3.81 in the same period. It has Quick Ratio of 2.58 while making debt-to-equity ratio of 0.83. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGC, volatility over the week remained 6.46% while standing at 8.46% over the month.
Stock’s fiscal year EPS is expected to rise by 49.04% while it is estimated to increase by 77.11% in next year. EPS is likely to grow at an annualized rate of 58.68% for next 5-years, compared to annual growth of 20.88% made by the stock over the past 5-years.
Coverage by Bernstein stated Canopy Growth Corporation (CGC) stock as an Underperform in their note to investors on November 02, 2022, suggesting a price target of $1.50 for the stock. Stock get an Underweight rating from Barclays on March 22, 2022.
